Amneal Pharmaceuticals, Inc. AMRX Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s interest paid?
- Amneal Pharmaceuticals, Inc. (AMRX) reported interest paid of $56.45M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s interest paid changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s interest paid increased by 0.2% year-over-year, from $56.32M to $56.45M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s interest paid has grown at a 12.9% compound annual growth rate (CAGR), from $121.75M to $197.85M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.